Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2022 | 05-2022 | 02-2022 | 11-2021 | 08-2021 | |
| Sales | 111 | 100 | 31 | 14 | 31 |
| Cost of Goods | 41 | 19 | 6 | 6 | 20 |
| Gross Profit | 70 | 81 | 24 | 8 | 11 |
| Operating Expenses | 1,583 | 2,499 | 1,473 | 2,012 | 1,440 |
| Operating Income | -1,513 | -2,418 | -1,449 | -2,003 | -1,429 |
| Other Income | 0 | 0 | 0 | 0 | 126 |
| Pre-tax Income | -1,513 | -2,418 | -1,449 | -2,003 | -1,303 |
| Net Income Continuous | -1,513 | -2,418 | -1,449 | -2,003 | -1,303 |
| Minority Interests | 46 | 35 | 23 | 10 | 125 |
| Net Income | $-1,467 | $-2,383 | $-1,426 | $-1,993 | $-1,178 |
| EBITDA(a) | $-1,450 | $-2,394 | $-1,423 | $-1,976 | $-1,365 |